
Mastectomy Surgery - Breast Removal Surgery
Of 931 women who had a mastectomy without rebuilding the breast, 73.7 percent said that was their first choice. What most predicted being unhappy afterwards was whether their surgeon had supported the decision.
About This Department
Of 931 women who had a mastectomy and did not have the breast rebuilt, 73.7 percent said that was their first choice instead of something they settled for. What most strongly predicted being unhappy afterwards was neither the operation nor their body, but whether their surgeon had supported the decision, which carried nearly four times the odds of dissatisfaction when that support was missing. Removing a breast is one operation with a great many choices bolted onto it, and this page is about the choices.
Free consultation
Ask what kind of mastectomy, and what happens to the skin and the nipple
Four different operations go by this name, and which one you are offered decides what you look like afterwards and what reconstruction is possible. Send the biopsy report with the receptor results, the grade and the HER2 status, the mammogram and ultrasound reports, the breast MRI if you have had one, the armpit ultrasound and any node biopsy, the genetic test result if you have had one, and your medication list. A breast surgeon and a reconstructive surgeon review the file together and tell you which type is appropriate, what the reconstruction options are, and what going without one would mean. No fee, no obligation, and a coordinator replies in your own language.
Four operations, one name
Mastectomy means removing the breast tissue. How much skin and which structures go with it varies enormously, and the word on your consent form should say which of the four is planned.
An older radical mastectomy, which removed the chest muscle as well, has essentially disappeared from practice, so if anybody uses the word radical to you, ask whether they mean the modified version, because the two operations leave very different chests.
The day itself
Why a breast comes off
Six reasons account for nearly all of them, and they are not equally strong.
- Disease too extensive to remove with a margin. Cancer in several parts of the breast, or suspicious calcification spread across it. The strongest reason on the list and the one that is genuinely not negotiable.
- Radiotherapy is impossible. Usually because the chest has been irradiated before. Conservation without radiotherapy is a different proposition, so this reason converts many women to mastectomy on its own.
- Margins that will not clear. After one or two attempts at conservation, the operation is telling you something about how far the disease reaches through the breast.
- Inflammatory breast cancer. A distinct disease with a distinct sequence, and removing the breast is always part of it.
- Tumor size against breast size. The weakest reason on this list, because reshaping techniques and drug treatment given before surgery have both moved the boundary a long way. Worth a second opinion before you accept it.
- You would rather not keep the breast. Entirely legitimate, and a common choice. Somebody who does not want years of scans and worry is making a decision about her life and not about her tumor, and it should be respected rather than argued with.
The three ways forward
Once the breast is coming off, three routes exist and all three are legitimate endings.
- Nothing. A flat chest, closed carefully. The shortest recovery, no foreign material, no further operations, and an external prosthesis available if you want one, and it was chosen first instead of settled for by nearly three-quarters of the women in the largest survey of this group.
- An implant. A silicone or saline device, either placed at the same sitting or reached in stages through a tissue expander that is gradually filled, and it is the shorter reconstruction with no second wound elsewhere on the body, and the one with the higher long-term failure rate.
- Your own tissue. Skin and fat taken from the abdomen, and less often the back or the thigh, transferred with its blood supply and reconnected under a microscope, which makes it a far bigger operation with a second scar, and the one that ages best and tolerates radiotherapy best.
One long-range comparison is worth carrying into the decision. A Texas registry study surveyed 647 women about ten years after diagnosis, comparing breast conservation with radiotherapy against mastectomy and reconstruction. Satisfaction with the breasts did not differ, and neither did physical wellbeing. The mastectomy and reconstruction group scored significantly worse on psychosocial wellbeing and on sexual wellbeing a decade on. Decisional regret did not differ between the groups, which is the finding that matters most here, because it says women in both groups largely stood by the choice they made.
Implant or your own tissue
An American consortium followed 2,343 women having reconstruction at eleven centers and reported both the complications and what the patients themselves said two years later, and the two halves of that work point in different directions, which is exactly why the choice is hard.
This table scrolls sideways on a narrow screen. Swipe or drag to see every column.
| What you are comparing | Implant or expander | Your own tissue |
|---|---|---|
| Complications in the first two years | The lower rate, and the comparison group against which the others were measured. | Higher. An abdominal free flap carried an odds ratio of 1.97 for any complication, with 32.9 percent of the whole cohort having one. |
| The reconstruction failing outright | 7.1 percent, the highest of any technique in the study. | 1.3 percent for an abdominal free flap, and between 1.2 and 2.8 percent for the other flap types. |
| Satisfaction with the breasts at two years | Lower by 7.94 points on a validated questionnaire, with a confidence interval of 5.68 to 10.20. | Higher, and also ahead on psychosocial wellbeing and on sexual wellbeing. |
| If radiotherapy is coming | Reconstruction failed in 21 percent of 80 irradiated patients in one series, with severe capsular hardening in 16.9 percent. | No failures at all among the 29 irradiated patients in that same series, and higher satisfaction scores. |
| What it costs you elsewhere | Nothing. No second wound, and a shorter operation and hospital stay. | A scar across the abdomen or the back, a longer recovery, and weakness in the abdominal wall with some of the older techniques. |
| Over the following decades | Implants are not lifetime devices and most women will need at least one further operation. | Behaves like the rest of your body, gaining and losing weight with you, and generally needs nothing further. |
Now or later
Reconstruction at the same sitting gives you the skin envelope, one anesthetic, and no period of living with a flat chest. Reconstruction later means two operations and a wait, and it lets the cancer treatment finish before anything is built, and although most units default to doing it immediately, the evidence for that default is thinner than the enthusiasm around it suggests. In the same American consortium, 151 women had delayed reconstruction and 1,806 had it immediately, and the delayed group had lower odds of any complication at 0.38, lower odds of a major complication at 0.52, and a failure rate of 1.3 percent against 6 percent. Satisfaction and wellbeing at two years did not differ between them.
Immediate reconstruction pushed the start of chemotherapy back by an average of 3.50 days across 29 studies and roughly 156,000 women. Statistically real, and clinically almost nothing. The odds of a delay beyond 90 days were not raised at all.
So the timing argument is not about delaying chemotherapy, which it barely does. What it is about is complications, which immediate reconstruction roughly doubles at an odds ratio of 2.04 in that same analysis, and that has to be weighed against the thing nobody measures well, which is what it is like to wake up without a breast and wait a year. Some women find that period intolerable and some find it a relief to have one thing at a time. That preference is legitimate data and it belongs in the decision alongside the odds ratios.
Radiotherapy afterwards
Many women assume that removing the breast removes the need for radiotherapy. Sometimes it does. Whether it does turns almost entirely on the lymph nodes, and a pooled analysis of 8,135 women across 22 randomized trials divided them into three groups.
- No positive nodes. Among 700 such women, radiotherapy did nothing measurable. Recurrence carried a rate ratio of 1.06 and breast cancer mortality 1.18, both with confidence intervals crossing one. No benefit was demonstrated in this group.
- One to three positive nodes. Among 1,314 women, radiotherapy cut recurrence at a rate ratio of 0.68 and breast cancer mortality at 0.80, with a confidence interval of 0.67 to 0.95, and this was the finding that changed practice, because women in this group were previously left untreated as often as not.
- Four or more positive nodes. Among 1,772 women, recurrence fell at a rate ratio of 0.79 and mortality at 0.87. Radiotherapy has been standard here for decades and remains so.
- What it means for a reconstruction. If radiotherapy is likely, the reconstruction decision changes. In a study of 109 irradiated women, implant-based reconstructions failed in 21 percent while none of the reconstructions using the patient's own tissue failed, and satisfaction scores were significantly higher in the flap group.
Sequencing is the practical consequence, and it is a question to raise before the operation instead of afterwards, so ask whether radiotherapy is expected and, if the answer is probably, ask what that means for the reconstruction being proposed to you.
Choosing to stay flat
Reconstruction is presented as the default in most consultations, and staying flat is presented as what happens when reconstruction is not possible. The largest survey of women who made that choice tells a different story.
What decides satisfaction
The same survey looked at what separated the women who were happy with their decision from the women who were not, and the answer is uncomfortable for the profession.
A surgeon who did not support the decision carried odds of 3.85 for the patient being dissatisfied afterwards. Being given adequate information about the options cut the odds of dissatisfaction to 0.48, and having a surgeon whose practice was specialized in breast surgery cut them to 0.56.
Two of those three findings are about the conversation rather than the operation. Neither the scalpel nor the anatomy explains them. What they describe is a woman leaving a consultation either believing her decision was heard or believing she had to defend it, and that difference following her for years afterwards. A body mass index of 30 or above also predicted dissatisfaction, at odds of 2.74, which points at the technical difficulty of getting a smooth flat contour on a larger chest and is worth raising directly with the surgeon before the operation. If you feel you are being steered, say so out loud and ask for the reasoning. A good unit will give you one.
Keeping the nipple
Nipple-sparing mastectomy gives the best cosmetic result available after breast removal. Two separate questions decide whether it suits you, and they have different answers.
Pain and lost sensation
Two consequences of this operation get mentioned far less often than they should and both are permanent for some women, the first being chronic pain in the chest, armpit or inner arm that lasts beyond healing and is sometimes burning or electrical in character. Published estimates put it somewhere between 28 and 52 percent, which is a wide range reflecting how differently studies define it, and the risk factors that show up consistently are younger age, extensive surgery in the armpit, a total mastectomy rather than a smaller operation, and having chronic pain somewhere else already. Treatments exist, from local anesthetic blocks to nerve pain medication to psychological approaches, and the evidence behind all of them is thin and inconsistent, but what matters practically is that this is a recognized condition and not something you are imagining, and that saying so early gets it treated earlier. Ask before the operation what this unit does about it, because the units that answer well are the ones that offer a nerve block at the time of surgery and a named person to raise it with afterwards.
Numbness is the second. Removing breast tissue divides the nerves supplying sensation to the skin over it, so the chest is usually numb afterwards, and that holds whether or not the breast is rebuilt. A reconstructed breast looks like a breast and generally does not feel like one. Surgeons have begun reconnecting those nerves during reconstruction, and in a study of 132 patients the ones who had it reported significantly better psychosocial wellbeing at 71.6 against 62.8 on a validated scale, and better sexual wellbeing at 56.9 against 47.3. The technique is available in relatively few centers and it is worth asking about if reconstruction is on your list.
Implants, honestly
If an implant is part of your plan, two specific things deserve saying plainly instead of being left for you to find on the internet at two in the morning.
Above the muscle or beneath it
Implants were traditionally placed under the chest muscle and increasingly they are placed above it, and a prospective comparison of 94 patients found that the group with the implant under the muscle reported more pain and used more painkillers over the first fortnight. Animation deformity, where the reconstructed breast moves and distorts when the chest muscle contracts, did not occur at all in the group with the implant above the muscle. Capsular hardening was more frequent below it. The trade-off runs the other way on appearance, since the outline of the implant was more visible when it sat above the muscle. Satisfaction and physical wellbeing at twelve and twenty-four months favored the position above the muscle, though only in patients whose skin was good enough to support an implant sitting there.
The lymphoma associated with textured implants
A rare cancer of the immune system can develop in the scar capsule around a breast implant, years after it is placed. It is not breast cancer. It is not usually fatal when caught early, and its association is with textured implant surfaces and not smooth ones. Estimates of how common it is have risen as reporting improved, and a review putting the numbers together gave a figure of one in 2,832 for the most heavily textured category of implant, while stressing that the denominators are unreliable because implant registries are patchy and cases go unreported. An American consensus review of 145 papers reached the same broad conclusion about texture. The practical instruction is short. Ask what surface your implant has, get the make, model and lot number in writing before you leave, and report any new swelling of the reconstructed breast years later and do not assume it is nothing.
Complications by the numbers
A mastectomy on its own is a safe operation with a short list of problems, and almost everything in the table below becomes more likely once a reconstruction is added, which is the trade being made.
This table scrolls sideways on a narrow screen. Swipe or drag to see every column.
| Problem | How common | What is done |
|---|---|---|
| Fluid collecting under the skin | The commonest problem of all, and the reason drains are used. | Drained with a needle in clinic, sometimes repeatedly over several weeks. Rarely needs an operation. |
| Skin or nipple losing its blood supply | 23.3 percent in a prospective series of 515 nipple-sparing operations, mostly partial thickness. | Dressings and time for the superficial cases. Full thickness loss needs the dead skin removed and sometimes costs the implant. |
| Infection | 9.8 percent wound infection across 2,343 reconstructions at eleven centers. | Antibiotics, and where an implant is infected it usually has to come out and go back later. |
| The reconstruction failing | 7.1 percent for implants and expanders against 1.3 percent for an abdominal free flap. It rises to 21 percent for implants after radiotherapy. | Removal, a period flat, and a different technique later if you want one. |
| Returning to the operating room | 19.3 percent of reconstruction patients had a complication requiring another procedure within two years. | Depends entirely on the cause. Ask any unit for its own figure and not the published one. |
| Long-term pain | Reported in 28 to 52 percent of patients, depending on how it is defined. | Nerve pain medication, blocks, physiotherapy and psychological approaches. Say something early. |
| Arm swelling | Driven by armpit surgery and not by the mastectomy itself. | Compression and specialist physiotherapy. This is why a sentinel node biopsy and a full clearance are not interchangeable. |
Without a cancer
Some women have both breasts removed with no cancer present because a genetic result puts their lifetime risk very high, and two questions arise from that decision with different answers, which is why they are worth asking separately.
How much cancer it prevents
Cancers prevented is the part that is not in dispute. Among 460 carriers who chose risk-reducing surgery and 745 who chose imaging surveillance instead, the annual rate of new breast cancer was 2.4 percent overall and fell to 0.15 percent after the operation, a relative reduction of 94 percent. Nine women, about 2 percent, turned out to have a cancer nobody had detected, found in the tissue removed at the operation itself.
Whether it makes you live longer
Here the evidence is divided, and both halves belong in the conversation. A Dutch cohort followed carriers for a mean of 10.3 years and found that among BRCA1 carriers, risk-reducing surgery was associated with lower overall mortality at a hazard ratio of 0.40 and dramatically lower breast cancer mortality at 0.06, with breast cancer specific survival at age 65 running at 99.7 percent against 93 percent under surveillance. For BRCA2 carriers the mortality difference did not reach statistical significance. The more recent study found breast cancer deaths of two in the surgery group and four in the surveillance group, a difference that was not statistically significant. Read those together and the honest position is that the operation reliably prevents cancers, that a survival benefit is well supported for BRCA1 and less certain for BRCA2, and that surveillance remains a defensible choice for a woman who prefers it. This is a decision to take slowly, with a genetic counselor, and it should never be bolted onto a decision about a cancer you already have.
Recovery and flying home
A mastectomy alone usually means one night, occasionally none. With an implant reconstruction expect one or two, and with tissue transferred from the abdomen expect four to six, because the blood supply to the flap is monitored closely for the first days. Drains are the thing that shapes the early weeks. They stay until the fluid coming out drops below an agreed volume, which is somewhere between five days and a fortnight, and you will be taught to empty and record them. That teaching is worth taking seriously, because a drain removed too early is the commonest reason for repeated needle drainage afterwards.
Shoulder exercises begin within a day or two and they are not optional. A shoulder protected for a fortnight stiffens, and unstiffening it takes months. Desk work is reasonable at around two to three weeks after a mastectomy alone and considerably later after a flap. Flying is generally cleared at seven to ten days after a mastectomy with or without an implant, and at around two to three weeks after tissue transfer, and later again if a drain is still in. Ask for the clearance in writing if your airline or insurer wants one.
Once you are back home the follow-up has three strands. A wound and drain check in the first fortnight with a doctor or nurse near you. An oncology appointment to start endocrine therapy or arrange chemotherapy and radiotherapy, booked before you fly. And, where a reconstruction is in progress, a plan for the expander fills or the second stage, which needs a named surgeon at home or a scheduled return. Get in touch about redness spreading from a scar, pain increasing after the third day, a fever, discharge, a wound edge opening, a reconstructed breast that swells or changes color, or skin over an implant that darkens. The last two need to be seen the same day. None of that list is a reason to be frightened of the operation, and every item on it is treatable when somebody hears about it in time, which is the only reason it is written out here in this much detail.
Questions to ask
Start with which of the four operations is planned and whether the skin or the nipple is being kept, since that single answer determines almost everything about the result. Ask what is happening to the armpit, and whether it is a sentinel node biopsy or a clearance, because the arm consequences differ enormously between them. Ask whether radiotherapy is expected afterwards, and if it is likely, ask what that means for the reconstruction being offered, given that implants failed in 21 percent of irradiated patients in one series while flaps did not fail at all.
Then ask the questions about the choices. Whether a delayed reconstruction has been discussed as a real option rather than a fallback, since the delayed group had fewer complications and the same satisfaction two years on. What a flat closure would look like in your case and who in the unit does them well, and if an implant is planned, what surface it has, whether it sits above or below the muscle, and what the make, model and lot number are. And finally, ask this surgeon's own complication and reoperation rates and not the published ones. A team that knows its own numbers is a team that measures itself.
Reading a quote
No figure appears on this page, and quotes for this operation are the hardest in breast surgery to compare, because a mastectomy alone and a mastectomy with a flap reconstruction are different undertakings that arrive under one heading. Six things belong in writing. Which of the four operations the quote covers, since a nipple-sparing procedure and a modified radical are not the same piece of work, and whether reconstruction is included and if so which type, because an implant and a microsurgical flap sit far apart on any price list. Whether the second stage is included where a tissue expander is being used, given that the expander is only half the job. Whether the armpit procedure is inside or added. Whether the pathology examination is included, which is the report the rest of your treatment is built from, and how many nights are budgeted, given the difference between one night for a mastectomy and five or six for a flap.
Your own file moves the total more here than almost anywhere in this specialty. Whether you are having a reconstruction at all, which type, whether both sides are being operated on and whether the armpit is being cleared are the four variables that decide the number.
Packages published by Turkish hospitals and medical travel agencies for breast cancer surgery generally include the airport transfer, pre-operative testing, the surgeon and anesthesia fees, the operating room, the planned nights, the pathology, an interpreter and the review before departure. They generally exclude flights, insurance, radiotherapy, drug treatment, the second stage of a reconstruction, treatment of a complication and hotel stays past an agreed number. Read what arrives against both lists.
Coming to Istanbul
Ten to fourteen days covers a mastectomy with or without an implant, assuming the diagnostic work is already done, while a reconstruction using your own tissue needs longer, in the region of three weeks, because the hospital stay is longer and flying is cleared later. Assessment and the multidisciplinary meeting fill the first days, the operation takes a morning or most of a day, and the pathology report decides how long you stay after that. Send the biopsy report before anything else, with the receptor status, the HER2 result and the grade written out. Add the mammogram and ultrasound reports with the measurements, any breast MRI, the armpit ultrasound and any node biopsy, the genetic test result if you have one, and your medication list. If a previous surgeon recommended a mastectomy, send that recommendation in whatever form you have it, because a second opinion has to engage with the specific reason given rather than the conclusion.
Say in your first message whether you want a reconstruction, whether you would consider staying flat, and how you feel about implants, because those three answers change which surgeons need to be in the room. Somebody who wants a flat closure needs a surgeon who does them properly and says so, and that is a reasonable thing to ask for by name. Only one coordinator holds your file from the first message to discharge, and the international patients team works in English, Arabic, French, Russian, Serbian, Romanian and Spanish, with other languages arranged on request. Ask in your first message if you would prefer a female physician. Someone can stay overnight with you on the ward, where the rooms carry a companion bed. Meals from the hospital kitchen cover halal, vegetarian and diabetic diets and a prayer room is available. The international patients office books accommodation for both of you, arranges the airport transfer and daily transport, and prepares the appointment confirmation and the invitation letter naming the hospital and your treating doctor for a medical visa application, around ten days before travel.
Take home the pathology report itself and not a summary, with the tumor size and type, the grade, the margin status, the number of nodes removed and involved, and the full receptor results. Take the operation note, which should name which type of mastectomy was performed and what was done to the armpit. If an implant was used, take the make, model, size and lot number, because you will need them years from now and reconstructing that information later is difficult. Add the multidisciplinary meeting conclusion with its recommendation about radiotherapy and drug treatment. Address the file to a breast oncologist near you and book that appointment before you fly. Once you are back home, your coordinator stays reachable on the same WhatsApp number, so a question about a drain or a line in the report reaches somebody with your notes in front of them. Keep that number long after the wounds have healed, because the questions that matter most in this operation arrive months and years later, when a reconstruction needs revising or somebody at home asks exactly what was implanted.
Mastectomy FAQ
Can I keep my nipple?
Do I have to have a reconstruction?
Is an implant or my own tissue better?
Should the reconstruction happen at the same time?
Will I still need radiotherapy after the breast is removed?
What if I need radiotherapy and want an implant?
Is it true that implants can cause a lymphoma?
Will my chest be numb, and will it hurt?
I carry a BRCA mutation and have no cancer. Should I have both removed?
How long should I stay in Turkey?
References
- Rohrich RN, Soltani H, Snee I, Fan KL, Lesnikoski BA, De La Cruz LM. A decade later, an updated systematic review and meta-analysis of overall survival, disease-free survival, local recurrence and nipple-areolar recurrence following nipple-sparing mastectomy. Annals of Surgical Oncology. 2026.
- Ma LX, Michaels AY, Ginter PS. Subareolar tissue biopsy predicts occult nipple involvement in nipple-sparing mastectomies. American Journal of Clinical Pathology. 2022;157(2):266-272.
- Moo TA, Nelson JA, Sevilimedu V, Charyn J, Le TV, Allen RJ, Mehrara BJ, Barrio AV, Capko DM, Pilewskie M, Heerdt AS, Tadros AB, Gemignani ML, Morrow M, Sacchini V. Strategies to avoid mastectomy skin-flap necrosis during nipple-sparing mastectomy. British Journal of Surgery. 2023;110(7):831-838.
- Yoon AP, Qi J, Brown DL, Kim HM, Hamill JB, Erdmann-Sager J, Pusic AL, Wilkins EG. Outcomes of immediate versus delayed breast reconstruction, results of a multicenter prospective study. The Breast. 2018;37:72-79.
- Cook P, Yin G, Ayeni FE, Eslick GD, Edirimanne S. Does immediate breast reconstruction lead to a delay in adjuvant chemotherapy for breast cancer? A meta-analysis and systematic review. Clinical Breast Cancer. 2023;23(5):e285-e295.
- Bennett KG, Qi J, Kim HM, Hamill JB, Pusic AL, Wilkins EG. Comparison of 2-year complication rates among common techniques for postmastectomy breast reconstruction. JAMA Surgery. 2018;153(10):901-908.
- Santosa KB, Qi J, Kim HM, Hamill JB, Wilkins EG, Pusic AL. Long-term patient-reported outcomes in postmastectomy breast reconstruction. JAMA Surgery. 2018;153(10):891-899.
- Xiao X, Feng Y, Zhu Z, Tang Y, Wu Y, Zhang X, Zhou J, Zhou Y, Du Z. Prepectoral versus subpectoral dual-plane direct-to-implant breast reconstruction with the TiLoop Bra, a single-center prospective cohort study. Plastic and Reconstructive Surgery. 2025;156(6):710e-720e.
- McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S, for the Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality, meta-analysis of individual patient data for 8135 women in 22 randomized trials. The Lancet. 2014;383(9935):2127-2135.
- Reinders FCJ, Young-Afat DA, Batenburg MCT, Bruekers SE, van Amerongen EA, Macare van Maurik JFM, Braakenburg A, Zonnevylle E, Hoefkens M, Teunis T, Verkooijen HM, van den Bongard HJGD, Maarse W. Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction. Breast Cancer. 2020;27(3):435-444.
- Clemens MW, Myckatyn TM, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, Horwitz SM, Hunt KK, Kadin ME, McCarthy CM, Miranda RN, Prince HM, Santanelli di Pompeo F, Holmes SD, Phillips LG. American Association of Plastic Surgeons consensus on breast implant-associated anaplastic large-cell lymphoma. Plastic and Reconstructive Surgery. 2024;154(3):473-483.
- Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plastic and Reconstructive Surgery. 2019;143(3S):30S-40S.
- Baker JL, Dizon DS, Wenziger CM, Streja E, Thompson CK, Lee MK, DiNome ML, Attai DJ. Going flat after mastectomy, patient-reported outcomes by online survey. Annals of Surgical Oncology. 2021;28(5):2493-2505.
- Khan S, Chiu AP, Payne C, Palmquist E, Curatolo M. Chronic pain after mastectomy, current knowledge and knowledge gaps. Minerva Anestesiologica. 2026;92(6):622-631.
- Shyu S, Chang TN, Lu JC, Chen CF, Cheong DC, Kao SW, Kuo WL, Huang JJ. Breast neurotization along with breast reconstruction after nipple sparing mastectomy enhances quality of life and reduces denervation symptoms in patient-reported outcome, a prospective cohort study. International Journal of Surgery. 2025;111(5):3235-3247.
- Sibia US, Klune JR, Turcotte JJ, Holton LH, Riker AI. Hospital-based same-day compared to overnight-stay mastectomy, an American College of Surgeons National Surgical Quality Improvement Program analysis. Ochsner Journal. 2022;22(2):139-145.
- Heemskerk-Gerritsen BAM, Jager A, Koppert LB, Obdeijn AIM, Collee M, Meijers-Heijboer HEJ, Jenner DJ, Oldenburg HSA, van Engelen K, de Vries J, van Asperen CJ, Devilee P, Blok MJ, Kets CM, Ausems MGEM, Seynaeve C, Rookus MA, Hooning MJ. Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 2019;177(3):723-733.
- Gandhi A, Howell SJ, Harkness EF, Woodward E, Lalloo F, Forde C, Harvey J, Highton L, Flaum N, Evans DG. Survival outcomes with or without risk-reducing mastectomy in BRCA1 and BRCA2 pathogenic variant carriers. Journal of Clinical Oncology. 2026;44(10):874-882.
- Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, Hoffman KE, Smith GL, Jagsi R, Peterson SK, Smith BD. Long-term quality of life in patients with breast cancer after breast conservation versus mastectomy and reconstruction. JAMA Surgery. 2022;157(6):e220631.
Editor's note
Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Hatice Deniz BÖLER, General Surgery.
Medically reviewed by

Prof. Dr. Hatice Deniz BÖLER
General Surgery
Related Treatments
View All
Bariatric Surgery - Weight Loss Surgery
Followed for 24 years, people who had weight loss surgery lived a median of 3.0 years longer than those who did not, and 5.5 years less than the general population. Both numbers come from the same study.

Breast Cancer Surgery
Across 202,934 women with the same early disease, the proportion who kept the breast ran from 58.5 to 75.5 percent depending on the region. Breast cancer surgery is not one decision. It is four, and this page maps them.

Breast Conserving Surgery
Two hundred and four women with two or three cancers in the same breast kept that breast, and recurrence at five years was 3.1 percent. Most of the reasons women are told they cannot keep the breast have quietly stopped being true.

Breast Lump Removal
Of 3,305 people under forty seen at one breast clinic, 29 had cancer. Most lumps are something else, and most of those never need an operation. This page covers how to tell which lump yours is and when removal earns its place.

Central Venous Port Implantation
A port is implanted in half an hour and then kept for years. Almost everything that later goes wrong with it was settled in that half hour, or is settled by how the device is flushed and accessed every week.